Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone/Naloxone for Opioid-Induced Constipation in Non-Malignant Pain
NCT00412100Phase 3Completed
- Sponsor
- Mundipharma
- Start
- Apr 2006
- Primary completion
- Jul 2008
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of oxycodone + naloxone in pain, opioid-induced constipation (OIC), sponsored by Mundipharma. Started Apr 2006; status: completed.
02
Drugs
oxycodone + naloxone
03
Conditions
painopioid-induced constipation (OIC)
Beyond the preview
Go deeper on NCT00412100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00412100.